C. Allison Stewart
The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)Emory University(US)Northeast Georgia Medical Center(US)
Publications by Year
Research Areas
Lung Cancer Research Studies, Microtubule and mitosis dynamics, Cancer Mechanisms and Therapy, Phagocytosis and Immune Regulation, Neuroendocrine Tumor Research Advances
Most-Cited Works
- → Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities(2021)886 cited
- → Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer(2020)361 cited
- → Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer(2017)224 cited
- → STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype(2020)200 cited
- → CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib(2017)192 cited
- → Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC